Verax Biomedical Incorporated – Trademark Portfolio
Entity Type: 03
Verax Biomedical Incorporated owns a portfolio of 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as PGD, PAN GENERA, VERAX BIOMEDICAL, PLATELET PGD PRIME, and PAN GENERA DETECTION. Of these, 9 are registered. The portfolio spans 3 Nice Classification classes, led by Class 10 (Medical Apparatus) and Class 5 (Pharmaceuticals). Headquartered in Marlborough, MA.
148 Bartlett Street
Marlborough, MA 01752
Showing of trademarks Trademarks
Trademark Classifications
Verax Biomedical Incorporated's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Verax Biomedical Incorporated have?
Verax Biomedical Incorporated has 16 U.S. trademarks filed with the USPTO. Of these, 9 registered, 4 abandoned, 3 cancelled.
What trademark classes does Verax Biomedical Incorporated file in?
Verax Biomedical Incorporated files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 16 (Paper Goods). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Verax Biomedical Incorporated's most well-known trademarks?
Verax Biomedical Incorporated's registered trademark portfolio includes well-known marks such as PGD, PAN GENERA, VERAX BIOMEDICAL, PLATELET PGD PRIME, and PAN GENERA DETECTION. These are among 9 currently registered trademarks in the portfolio.
What is Verax Biomedical Incorporated's trademark registration success rate?
Verax Biomedical Incorporated has a 56% trademark registration rate, with 9 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.